Measles vaccination in Africa: by how much could routine coverage be improved?
WJ Edmunds
;
NJ Gay;
AM Henao Restrepo;
JM Olivé;
O Bele;
(2001)
Measles vaccination in Africa: by how much could routine coverage be improved?
Vaccine, 20 (1-2).
pp. 16-18.
ISSN 0264-410X
DOI: 10.1016/s0264-410x(01)00264-x
Assuming that the level of Bacille Calmette Guerin (BCG) coverage gives a measure of access to immunisation services, it is possible to derive what fraction of infants are not immunised against measles due to under-utilisation of existing services (rather than unavailability of services). According to the most recent official statistics, the overall coverage for measles vaccine is 53% in Africa (10% lower than for BCG). This difference amounts to 3 million African children who will not be vaccinated against measles this year even though they probably have access to immunisation services.
Item Type | Article |
---|---|
Keywords | Africa/epidemiology, BCG Vaccine, Developing Countries, Health Services Accessibility, Humans, Infant, Measles/mortality/prevention & control, *Measles Vaccine, Medically Underserved Area, Program Evaluation, Socioeconomic Factors, Vaccination/*utilization, Africa, epidemiology, BCG Vaccine, Developing Countries, Health Services Accessibility, Humans, Infant, Measles, mortality, prevention & control, Measles Vaccine, Medically Underserved Area, Program Evaluation, Socioeconomic Factors, Vaccination, utilization |
ISI | 171512000005 |
ORCID: https://orcid.org/0000-0002-9179-2917